Nicorandil: a Review of Its Use in the Management of Stable Angina Pectoris, Including High-risk Patients

Overview

Journal Drugs

Specialty Pharmacology

Date 2004 Aug 27

PMID 15329045

Citations 12

Authors

Dene Simpson

Keri Wellington

Affiliations

Soon will be listed here.

Abstract

Nicorandil (Adancor, Angicor, Dancor, Nikoril [Europe], Ikorel [Europe and Oceania], Sigmart [Japan, Korea and Taiwan]) is an adenosine triphosphate (ATP)-sensitive potassium (KATP) channel agonist with nitrate-like properties used in the management of stable angina pectoris. With well established monotherapeutic antianginal activity and a beneficial effect (when added to optimal antianginal therapy) on clinical outcomes in high-risk patients with stable angina, twice-daily oral nicorandil is a useful alternative or addition to other antianginal therapy.

Citing Articles

Improvement of coronary microcirculation in acute myocardial ischemia rats using a nanoscale carrier SiO@PEG loaded with Nicorandil.

Wang R, Mo Y, Liang Y, Liu Y, Sun Z, Shang W Drug Deliv Transl Res. 2025; .

PMID: 40053232 DOI: 10.1007/s13346-025-01820-0.

The ATP sensitive potassium channel (K) is a novel target for migraine drug development.

Clement A, Christensen S, Jansen-Olesen I, Olesen J, Guo S Front Mol Neurosci. 2023; 16:1182515.

PMID: 37456521 PMC: 10338883. DOI: 10.3389/fnmol.2023.1182515.

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database.

Yamashiro K, Jouta M, Hosomi K, Yokoyama S, Ozaki Y, Hirata A Sci Rep. 2022; 12(1):17652.

PMID: 36271126 PMC: 9587040. DOI: 10.1038/s41598-022-22257-2.

Recurrence of Takotsubo cardiomyopathy with coronary slow flow phenomenon.

Tokunou T, Sadamatsu K J Cardiol Cases. 2018; 5(2):e100-e106.

PMID: 30532915 PMC: 6265387. DOI: 10.1016/j.jccase.2011.10.003.

Evaluation of the effects of nicorandil and its molecular precursor (without radical NO) on proliferation and apoptosis of 786-cell.

de Paula N, Niwa A, Vesenick D, Panis C, Cecchini R, de Fatima A Cytotechnology. 2013; 65(5):839-50.

PMID: 23325113 PMC: 3967609. DOI: 10.1007/s10616-012-9524-4.

References

DORING G . Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients. J Cardiovasc Pharmacol. 1992; 20 Suppl 3:S74-81. View

. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002; 359(9314):1269-75. DOI: 10.1016/S0140-6736(02)08265-X. View

Rajaratnam R, Brieger D, Hawkins R, Freedman S . Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris. Am J Cardiol. 1999; 83(7):1120-4, A9. DOI: 10.1016/s0002-9149(99)00025-9. View

Iwai T, Tanonaka K, Motegi K, Inoue R, Kasahara S, Takeo S . Nicorandil preserves mitochondrial function during ischemia in perfused rat heart. Eur J Pharmacol. 2002; 446(1-3):119-27. DOI: 10.1016/s0014-2999(02)01645-x. View

Minamino T, Jiyoong K, Asakura M, Shintani Y, Asanuma H, Kitakaze M . Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic.... Circ J. 2004; 68(2):101-6. DOI: 10.1253/circj.68.101. View

Hughes L, Rose E, Lahiri A, Raftery E . Comparison of nicorandil and atenolol in stable angina pectoris. Am J Cardiol. 1990; 66(7):679-82. DOI: 10.1016/0002-9149(90)91129-t. View

Kato T, Kamiyama T, Maruyama Y, Tanaka S, Yoshimoto N . Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplasty. Am Heart J. 2001; 141(6):940-3. DOI: 10.1067/mhj.2001.114369. View

Saito S, Mizumura T, Takayama T, Honye J, Fukui T, Kamata T . Antiischemic effects of nicorandil during coronary angioplasty in humans. Cardiovasc Drugs Ther. 1995; 9 Suppl 2:257-63. DOI: 10.1007/BF00878473. View

Lee T, Su S, Chou T, Lee Y, Tsai C . Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation. 2002; 105(3):334-40. DOI: 10.1161/hc0302.102572. View

10.

Kobayashi Y, Goto Y, Daikoku S, Itoh A, Miyazaki S, Ohshima S . Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction. Jpn Circ J. 1998; 62(3):183-9. DOI: 10.1253/jcj.62.183. View

11.

Patel D, Purcell H, Fox K . Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and.... Eur Heart J. 1999; 20(1):51-7. DOI: 10.1053/euhj.1998.1354. View

12.

Krumenacker M, Roland E . Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. J Cardiovasc Pharmacol. 1992; 20 Suppl 3:S93-102. View

13.

Okamura A, Rakugi H, Ohishi M, Yanagitani Y, Shimizu M, Nishii T . Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin. J Am Coll Cardiol. 2001; 37(3):719-25. DOI: 10.1016/s0735-1097(00)01171-2. View

14.

Di Somma S, Liguori V, Petitto M, Carotenuto A, Bokor D, de Divitiis O . A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris. Cardiovasc Drugs Ther. 1993; 7(1):119-23. DOI: 10.1007/BF00878320. View

15.

Nameki M, Ishibashi I, Miyazaki Y, Sakai Y, Namikawa S, Kuriyama N . Comparison between nicorandil and magnesium as an adjunct cardioprotective agent to percutaneous coronary intervention in acute anterior myocardial infarction. Circ J. 2004; 68(3):192-7. DOI: 10.1253/circj.68.192. View

16.

Frampton J, Buckley M, Fitton A . Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs. 1992; 44(4):625-55. DOI: 10.2165/00003495-199244040-00008. View

17.

ORourke S . KATP channel activation mediates nicorandil-induced relaxation of nitrate-tolerant coronary arteries. J Cardiovasc Pharmacol. 1996; 27(6):831-7. DOI: 10.1097/00005344-199606000-00010. View

18.

Ashikaga T, Nishizaki M, Arita M, Yamawake N, Fujii H, Kishi Y . Opening of K(ATP) channel attenuates the increase in QT dispersion produced by the first balloon inflation during coronary angioplasty. Circ J. 2002; 66(5):469-72. DOI: 10.1253/circj.66.469. View

19.

Fukuda H, Luo C, Gu X, Guo L, Digerness S, Li J . The effect of K(atp)channel activation on myocardial cationic and energetic status during ischemia and reperfusion: role in cardioprotection. J Mol Cell Cardiol. 2001; 33(3):545-60. DOI: 10.1006/jmcc.2000.1328. View

20.

Galie N, Guarnieri C, Ussia G, Zimarino M, Traini A, Parlangeli R . Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol. 1995; 26(3):477-84. DOI: 10.1097/00005344-199509000-00019. View